RT10 high-quality products fast and safe delivery,99% high-purity, on-time shipment, reasonable price

Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor . Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual:Handling and Storage of Synthetic Peptides. Retatrutide is a new weight loss drug being experimented on by Eli Lilly, a pharmaceutical giant renowned for its breakthrough in diabetes and obesity treatment. Much like other weight loss drugs rolled out by Eli Lilly, Retatrutide is administered under the skin (subcutaneous route) per week and has yielded exceptional results in treating chronic diseases like diabetes and obesity compared to the predecessors.

1. Helps slow food leaving your stomach
2. Helps prevent your liver from making too much sugar
3. Helps the pancreas produce more insul when your blood sugar levels are high
4. Can help control blood glucose
5. Can reduce hyperglycemia, especially after meals
6. Can reduce fasting insul and fasting glucose
7. Can reduce hemoglobin A1c
8. Can decrease appetite and caloric intake, while inhibiting weight gain
9. Has been shown to lower triglyceride levels and oxidative stress from high LDL
10. 
11.